Cargando…

COVID-19-Schutz für immungeschwächte Patienten

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264303/
https://www.ncbi.nlm.nih.gov/pubmed/35821977
http://dx.doi.org/10.1007/s41969-022-00165-0
_version_ 1784742947831414784
collection PubMed
description
format Online
Article
Text
id pubmed-9264303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-92643032022-07-08 COVID-19-Schutz für immungeschwächte Patienten J Klin Endokrinol Stoffwechs Aktuell Springer Vienna 2022-07-08 2022 /pmc/articles/PMC9264303/ /pubmed/35821977 http://dx.doi.org/10.1007/s41969-022-00165-0 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Aktuell
COVID-19-Schutz für immungeschwächte Patienten
title COVID-19-Schutz für immungeschwächte Patienten
title_full COVID-19-Schutz für immungeschwächte Patienten
title_fullStr COVID-19-Schutz für immungeschwächte Patienten
title_full_unstemmed COVID-19-Schutz für immungeschwächte Patienten
title_short COVID-19-Schutz für immungeschwächte Patienten
title_sort covid-19-schutz für immungeschwächte patienten
topic Aktuell
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264303/
https://www.ncbi.nlm.nih.gov/pubmed/35821977
http://dx.doi.org/10.1007/s41969-022-00165-0